Join to View Full Profile
200 Medical Plaza, Suite B265Los Angeles, CA 90095
Phone+1 310-825-9775
Fax+1 310-825-9775
Dr. Nickols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2010 - 2014
University of California (Irvine)Internship, Internal Medicine, 2009 - 2010
David Geffen School of Medicine at UCLAClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2026
American Board of Radiology Radiation Oncology
Clinical Trials
- Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer Start of enrollment: 2018 Jul 01
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer Start of enrollment: 2021 Mar 17
Publications & Presentations
PubMed
- Setting the PACE for prostate radiotherapy.Nicholas G Nickols, Abhishek A Solanki
The Lancet. Oncology. 2025-07-01 - The Evolving Management of Radiorecurrent Prostate Cancer.Jacob Pozin, Menal Bhandari, Luca Valle, Nicholas G Nickols, Amar U Kishan
Seminars in Radiation Oncology. 2025-07-01 - Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometast...Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, Robert E Reiter, Alan Lee
European Urology Oncology. 2025-06-19
Press Mentions
Shorter Radiation Treatment After Surgery Found Safe for Prostate Cancer PatientsMay 14th, 2025- Three UCLA/VA Researchers to Be Honored by Secretary of Veterans AffairsMay 4th, 2023
- ‘STARPORT’ Trial Probes New Approach for Aggressive Prostate CancerAugust 16th, 2021
- Join now to see all
Grant Support
- Phase II Trial of targeted Radiation with no castration for mcrpc (POTENT-C)VA GREATER LOS ANGELES HEALTHCARE SYSTEM2024–2028
- Predicting Metastatic Progression of High Risk Localized Prostate CancerVA GREATER LOS ANGELES HEALTHCARE SYSTEM2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
